intermittent claudication Clinical Trials

9 recruitingLast updated: July 25, 2026

There are 9 actively recruiting intermittent claudication clinical trials across 6 countries. Studies span Not Applicable, Phase 3, Phase 2. Top locations include Chicago, Illinois, United States, Pittsburgh, Pennsylvania, United States, Downey, California, United States. Updated daily from ClinicalTrials.gov.


intermittent claudication Trials at a Glance

9 actively recruiting trials for intermittent claudication are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Chicago, Pittsburgh, and Downey. Lead sponsors running intermittent claudication studies include Northwestern University, I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, and Glasgow Caledonian University.

Browse intermittent claudication trials by phase

Treatments under study

About intermittent claudication Clinical Trials

Looking for clinical trials for intermittent claudication? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new intermittent claudication trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about intermittent claudication clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Predictors of Major Adverse Limb Events After Endovascular Iliac Stenting: a Real-world Cohort Study

Aortoiliac occlusive diseaseintermittent claudicationPeripheral Arterial Disease+1 more
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio98 enrolled1 locationNCT07672249
Recruiting
Not Applicable

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

intermittent claudicationstable coronary artery diseaseAcute Coronary Syndromes+1 more
Maria Cecilia Hospital60 enrolled1 locationNCT07588295
Recruiting
Phase 3

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

intermittent claudication
VA Office of Research and Development200 enrolled1 locationNCT05132439
Recruiting
Not Applicable

Motivating Physical Activity With Behavioural interVention and Electrical Stimulation Remotely in Intermittent Claudication

intermittent claudicationPeripheral Artery Disease
Glasgow Caledonian University48 enrolled1 locationNCT06114732
Recruiting
Phase 3

Improving Mobility After Revascularization in Peripheral Artery Disease

intermittent claudicationMobility LimitationPeripheral Artery Disease+2 more
Northwestern University386 enrolled7 locationsNCT06686121
Recruiting
Phase 2

Response to Exercise and Nitric Oxide in PAD

intermittent claudicationExercisePeripheral Artery Disease+1 more
Northwestern University200 enrolled2 locationsNCT06657976
Recruiting
Not Applicable

Personalised Multicomponent Exercise Programme in Peripheral Arterial Disease

intermittent claudicationPeripheral Arterial Disease
University of Trás-os-Montes and Alto Douro40 enrolled3 locationsNCT06410521
Recruiting
Not Applicable

Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark

intermittent claudication
Slagelse Hospital600 enrolled1 locationNCT06299956
Recruiting
Not Applicable

Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application

intermittent claudication
CHU de Reims52 enrolled1 locationNCT05457738